STUDY: FIRST TIME STROKE SURVIVORS HAVE SUBSTANTIAL IMMEDIATE AND ACCELERATED LONG TERM-COGNITIVE DECLINE New evidence points to vascular risk factors exerting impact on cognitive function years before stroke onset
SEGMENT
Filmed in Sydney | January 2025
New evidence from the Centre for Healthy Brain Ageing (CHeBA) indicates that older adults who experience a stroke for the first time will have substantial immediate and accelerated long term-cognitive decline.
Stroke is a leading cause of disability and dementia globally, with projections indicating a continued rise in both prevalence and burden. The new research, published in October 2024 in JAMA Network Open, looked at finding out exactly how a stroke impacts a person’s cognitive abilities.
Stroke occurs when blood flow to part of the brain is blocked or reduced, causing damage to brain cells. Previous research from the Centre has shown that more than a third of stroke survivors’ ability to think, remember and make decisions is significantly disadvantaged after stroke, with clear deficits in cognition or vascular dementia present.
Vascular dementia, the second most common type of dementia, is caused by reduced blood flow to the brain. The research, led by biostatistician and Research Associate Jess Lo, addressed many unanswered questions about this dementia type, which is yet to be studied as extensively as Alzheimer’s disease.
“Although we do experience changes to our brain functioning over time and as we age, certain medical conditions can potentially speed up these changes, which may lead to cognitive impairment or dementia,” says Lo.
The research analysed data from 14 studies that followed community dwelling older adults without a history of stroke or dementia, with an average age of 73 over many years, tracking their health and cognitive abilities. The studies, part of the CHeBA-led international Cohort Studies of Memory in an International Consortium (COSMIC), span 11 countries including Australia, Brazil, France and the US.
With data from 20,860 participants, the researchers identified people who experienced their first stroke during the study period.
The research also found that individuals who had a history of diabetes, hypertension, high cholesterol, cardiovascular disease, depression, smoked or were APOE4 carriers exhibited significantly faster cognitive decline before any stroke.
Senior author on the paper and Co-Director of the Centre for Healthy Brain Ageing (CHeBA), Professor Perminder Sachdev, said that this global collaborative study highlights the significant and lasting negative impact of stroke on brain cognition.
“Our findings can help clinicians better plan for the ongoing needs of stroke survivors who are at risk of disability and a lower quality of life,” said Professor Sachdev.
-
Op-Ed: CGT and proposed RDTI changes creating uncertainty in life sciences
Proposed Budget changes to the Research and Development Tax Incentive (RDTI) will disproportionally impact Australia’s biotech, medtech and health tech sector forcing more home-grown companies to consider moving overseas.
-
Harnessing the skillset and availability of the nation’s Exercise Physiologists and Scientists
Katie Lyndon MBA, BAppSci, ESSAF, FACHSM, CHE, AEP, AES, GAICD, CHIA, is an allied health professional and executive leader with nearly two decades of experience spanning executive leadership, delivery of strategic programs across the health system and clinical care.
As CEO of Exercise & Sports Science Australia (ESSA), Katie brings a unique blend of frontline experience and strategic vision to advance the profession and advocate for evidence-based exercise in preventive health and chronic disease management. Her long-standing commitment to ESSA includes serving as Board Vice President, Policy and Advocacy Manager, Standards Council member and ESSA Fellow.
-
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
